Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-30

Clinical Trial Update: Quality of Life in Patients With Hemorrhagic Telangiectasia

View source ↗

Summary

This clinical trial update describes a study assessing quality of life in patients with hereditary hemorrhagic telangiectasia. The trial is currently enrolling …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Essen | Conditions: Hereditary Hemorrhagic Telangiectasia | Status: ENROLLING_BY_INVITATION